Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BERKLEY W R CORP KCHV Kochav Defense Acquisition Corp. 13G/A 8.1% 5d
HORIZON KINETICS ASSET MANAGEMENT LLC LB LandBridge Corp 13G/A 19.7% 5d
GOLDMAN SACHS GROUP INC RNGT Range Capital Acquisition Corp II 13G 5.4% 5d
BERKLEY W R CORP OCAC Ocean Capital Acquisition Corp 13G 7.2% 5d
GOLDMAN SACHS GROUP INC REPL Replimune Group, Inc. 13G/A 3.3% 5d
BERKLEY W R CORP CAPN Cayson Acquisition Corp 13G/A 7.1% 5d
BERKLEY W R CORP SSEA Starry Sea Acquisition Corp 13G 9.8% 5d
BERKLEY W R CORP QUMS Quantumsphere Acquisition Corp 13G/A 9.5% 5d
BERKLEY W R CORP TVA Texas Ventures Acquisition III Corp 13G 8% 5d
Goldman Sachs Asset Management, L.P. KN Knowles Corp 13G/A 5% 5d
BERKLEY W R CORP WSTN Westin Acquisition Corp 13G 5.4% 5d
GOLDMAN SACHS GROUP INC PPLI People Inc 13G/A 3.7% 5d
BERKLEY W R CORP COLA Columbus Acquisition Corp 13G/A 8.9% 5d
BERKLEY W R CORP ATLQ Atlantic Acquisition Corp I 13G 6.6% 5d
GOLDMAN SACHS GROUP INC ATII Archimedes Tech SPAC Partners II Co. 13G 6.4% 5d
BAILLIE GIFFORD & CO WSE Wise Group plc 13G/A 9.1% 5d
TS Innovation Acquisitions Sponsor, L.L.C. LTCH Latch, Inc. 13D/A 4% 5d
American Ventures LLC, Series XII SHOT BNKK Bonk, Inc. 13G/A 0% 5d
Kapitalo Investimentos Ltda AUGO Aura Minerals Inc. 13G/A 4.9% 5d
FOUAD AHMED RBNE Robin Energy Ltd. 13G/A 0% 8d
The Column Group III GP, LP SRZN Surrozen, Inc. 13D/A 16.6% 8d
BAKER BROS. ADVISORS LP MDGL Madrigal Pharmaceuticals, Inc. 13D/A 9.99% 8d
Mangrove Coast Investment Limited XYF X Financial 13D 42.74% 8d
Elliott Investment Management L.P. TFPM Triple Flag Precious Metals Corp. 13D/A 64.8% 8d
Frisco Holding II HCA HCA Healthcare, Inc. 13D/A 18.6% 8d
Resolute Compo Holdings LLC GPGI GPGI, Inc. 13D/A 17% 8d
ICAHN CARL C CVI Cvr Energy Inc 13D/A 64.1% 8d
Resolute ManCo Holdings LLC RHLD Resolute Holdings Management, Inc. 13D/A 52.5% 8d
Anthony Pompliano SVIA Silvia, Inc. 13D/A 20% 8d
Corvus Capital Ltd. CDT CDT Equity Inc. 13D/A 16.8% 8d
Salem Investment Partners V, Limited Partnership ( ) GUER Guerrilla RF, Inc. 13D/A 9.3% 8d
RA CAPITAL MANAGEMENT, L.P. SLDB Solid Biosciences Inc. 13D/A 10.8% 8d
GIC Private Ltd MDLN Medline Inc. 13G/A 8.49% 8d
AMB Investments LLC GUER Guerrilla RF, Inc. 13D/A 18.7% 8d
Robert Nelsen VIR Vir Biotechnology, Inc. 13D/A 6.9% 8d
Saba Capital Management, L.P. ZTR Virtus Total Return Fund Inc. 13D/A 4.92% 8d
Saba Capital Management, L.P. ECF Ellsworth Growth & Income Fund Ltd 13D/A 13.48% 8d
Patriot Financial Partners III, L.P. MCB Metropolitan Bank Holding Corp. 13D/A 4.76% 8d
HGGC Fund IV GP, Ltd. UPLD Upland Software, Inc. 13D/A 21.76% 8d
Andrew D. Wingate, Lucinda Falk and Zena Tamler, not individually, but solely as co-trustees of DJPS P.G. Trust. H Hyatt Hotels Corp 13D/A 0.4% 8d
OPKO HEALTH, INC. COCP Cocrystal Pharma, Inc. 13D/A 29.6% 8d
Common Property Trust NRC Nrc Health 13D/A 40.6% 8d
Johnson & Johnson Innovation - JJDC, Inc. CTNM Contineum Therapeutics, Inc. 13G/A 5.6% 8d
AMTD Group Inc. HKD AMTD Digital Inc. 13D/A 62.3% 8d
AMTD Group Inc. TGE Generation Essentials Group 13D 95.7% 8d
MORGAN STANLEY DIN Dine Brands Global, Inc. 13G/A 0.5% 8d
Orbis Investment Management Limited FSV FirstService Corp 13G/A 7.7% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 60.09% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G/A 10.18% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 58.34% 8d